Overview
The world's healthcare champions — US pharma and devices beside Novo Nordisk, Roche, Novartis and AstraZeneca, around 125 companies.
Top Holdings
| Ticker | Holding | Weight |
|---|---|---|
| LLY | Eli Lilly & Co. | 9.8% |
| JNJ | Johnson & Johnson | 6.4% |
| ABBV | AbbVie Inc. | 5.2% |
| NOVO-B | Novo Nordisk | 4.4% |
| AZN | AstraZeneca | 3.9% |
| NOVN | Novartis AG | 3.7% |
| ROG | Roche Holding | 3.4% |
| MRK | Merck & Co. | 3.2% |
| ABT | Abbott Laboratories | 3.1% |
| UNH | UnitedHealth Group | 2.9% |
Fund Details
Investment Thesis
The obesity-drug duopoly is split across two continents — Lilly in Indianapolis, Novo in Copenhagen — and IXJ is the one sector fund that owns both at full weight, plus Europe's pharma giants trading cheaper than their US peers. The +16% year rode the sector's rehabilitation as drug-pricing fears faded. Healthcare demand is the closest thing equities have to a demographic certainty.
Who It's For
Healthcare allocators who want the global industry rather than its American half — the structural upgrade over XLV for the GLP-1 era and beyond.
10-Year History
| Year | Close | % Chg |
|---|---|---|
| 2016 | $49.71 | -- |
| 2017 | $58.65 | +18.0% |
| 2018 | $58.65 | +0.0% |
| 2019 | $70.97 | +21.0% |
| 2020 | $79.49 | +12.0% |
| 2021 | $93.00 | +17.0% |
| 2022 | $85.56 | -8.0% |
| 2023 | $87.27 | +2.0% |
| 2024 | $87.27 | +0.0% |
| 2025 | $96.00 | +10.0% |
| Year | Yield |
|---|---|
| 2016 | 1.80% |
| 2017 | 1.70% |
| 2018 | 1.80% |
| 2019 | 1.70% |
| 2020 | 1.50% |
| 2021 | 1.30% |
| 2022 | 1.60% |
| 2023 | 1.70% |
| 2024 | 1.60% |
| 2025 | 1.50% |
| Year | AUM | % Chg |
|---|---|---|
| 2016 | $1.5B | -- |
| 2017 | $1.8B | +20.0% |
| 2018 | $2B | +11.1% |
| 2019 | $2.5B | +25.0% |
| 2020 | $3B | +20.0% |
| 2021 | $3.8B | +26.7% |
| 2022 | $3.5B | -7.9% |
| 2023 | $3.5B | +0.0% |
| 2024 | $3.8B | +8.6% |
| 2025 | $4B | +5.3% |
Historical figures are ETFHub estimates modelled from asset-class return patterns and may differ from official fund records. Data as of September 2026.
Related US Sectors ETFs
Markets. Intelligence. Daily.
Full briefs on 350+ ETFs, curated daily ETF news, and a free weekly deep-dive newsletter — all on ETFHub.
Get the Free Weekly Brief Explore the ETF Portal Official Fund Page →